Patching adherence is linked to improved grating visual acuity

Article

Patching during the first six months after surgery is linked to improved grating visual acuity in infants with unilateral cataract.

Patching during the first six months after surgery is linked to improved grating visual acuity in infants with unilateral cataract, reveals a paper in Investigative Ophthalmology & Visual Science.

Dr Carolyn D. Drews-Botsch et al., Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, Georgia, USA, completed a randomized clinical trial of 108 infants with unilateral congenital cataract.

Patching was conducted one hour per day every month until the patient was eight months of age. The mean percentage of prescribed patching was used to measure adherence in a weeklong diary completed two months postoperatively. Recall interviews lasting 48 hours were also performed three and six months postoperatively.

Teller Acuity Cards were used to measure grating visual acuity within one month of the infant's first birthday. The link between grating acuity and patching was found with nonparametric correlations.

The results revealed that 84.3% of prescribed time and adherence did not change according to treatment. Adherence was found to be strongly associated with grating acuity, especially among pseudophakic patients compared to aphakic infants. Implanting an intraocular lens (IOL) was not linked to adherence.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.